Survival of diabetes and nondiabetes kidney transplant patients — Mayo Clinic Jan. 25, 2017 Overview Show transcript Overview Mayo Clinic researchers have discovered that the five-year survival of diabetic kidney transplant patients is now on par with the five-year survival of nondiabetic kidney recipients. These study findings represent significant improvements in the management of kidney transplant patients who have diabetes and pretransplant consequences of diabetes such as heart disease and high blood pressure. The study also suggests better prevention of post-transplant cardiac events and infections. Prior to 1996, the five-year mortality rate of diabetic kidney transplant patients was more than double that of nondiabetic kidney recipients. Share Doximity Facebook LinkedIn Twitter Print details Receive Mayo Clinic news in your inbox. Sign up Related ContentArticlePreventing glomerulonephritis after kidney transplantArticleMayo Clinic offers kidney transplant to patients with high BMI who were previously considered ineligible VID-20433404 Medical Professionals Survival of Diabetes and Non-Diabetes Kidney Transplant Patients - Mayo Clinic